文献速递气道管理术前评估与围术期医学

美国危重患者急性呼吸衰竭气管插管趋势与变异

Trends and Variations in Tracheal Intubation for Acute Respiration Failure in Critically Ill Patients in the United States.
PubMed 文献 · Anesth Analg · 2026-07-20

基于美国国家住院样本2016-2019年成人急性呼吸衰竭住院的观察性队列研究,共识别2,017,349例住院(全国约10,086,744例),其中21.3%需气管插管。气管插管比例从2016年23.8%降至2019年19.8%(P<.0001),插管患者死亡率稳定于约31%,未插管患者死亡率从8.1%降至6.6%;10.5%的插管率变异归因于收治医院,脓毒症是与插管最强相关的患者因素。

要点

  • 急性呼吸衰竭住院中21.3%需气管插管,插管比例逐年下降。
  • 插管患者死亡率约31%且稳定,未插管患者死亡率下降。
  • 10.5%插管率变异归因于收治医院,脓毒症是最强相关因素。

核心结论

  • 危重急性呼吸衰竭患者气管插管率随时间下降,插管患者死亡率无变化,而未插管患者死亡率同期下降。

研究设计与样本

  • 观察性队列研究,使用美国国家住院样本(National Inpatient Sample)纳入2016-2019年成人急性呼吸衰竭住院。
  • 共识别2,017,349例急性呼吸衰竭住院,代表全国10,086,744例(95%CI 9,957,967-10,215,520)。
  • 采用多变量逻辑回归分析插管相关因素及插管与死亡率关联,控制呼吸衰竭类型、人口学和合并症。

主要发现

  • 2,017,349例住院中215,346例(21.3%)需气管插管。
  • 急性呼吸衰竭病例从2016年1,872,519例增至2019年3,194,075例,插管比例从23.8%降至19.8%(P<.0001)。
  • 插管患者死亡率高于未插管患者(P<.001);插管患者死亡率2016年30.6%(95%CI 30.2-31.1)与2019年31.0%(95%CI 30.5-31.4)保持稳定。
  • 未插管患者死亡率从2016年8.1%(95%CI 7.9-8.3)降至2019年6.6%(95%CI 6.5-6.8)。
  • 插管率变异的10.5%归因于收治医院,脓毒症是与插管最强相关的患者因素。

关键数值与推荐

  • 插管患者更多为非白人男性、合并症负担更高、医疗补助保险、大城市教学医院住院。

临床怎么用

  • 麻醉科智能体应关注急性呼吸衰竭患者插管决策的医院间差异及脓毒症相关插管风险。
  • 插管患者死亡率高且稳定,提示需优化插管时机与围插管管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute respiratory failure (ARF) is a common indication for tracheal intubation in critically ill patients. This study sought to describe temporal trends and hospital variation in tracheal intubation among patients with ARF, identify factors associated with its use, and examine the relationship between tracheal intubation and hospital mortality. METHODS: We performed an observational cohort study of adult hospitalizations (2016-2019) for ARF using the National Inpatient Sample. We identified critically ill patients with ARF who required tracheal intubation and assessed outcomes, temporal trends in the incidence, and associated patient and hospital characteristics. Multivariable logistic regression was used to examine factors associated with the performance of tracheal intubation and to characterize the association between mortality and intubation status while controlling for type of respiratory failure, demographics, and patient comorbidities. RESULTS: A total of 2017,349 admissions with a diagnosis of ARF were identified, representing 10,086,744 (95% confidence interval [CI], 9957,967-10,215,520) cases nationwide. Of those, 2153,460 (21.3%) required tracheal intubation. Intubated patients were more likely to be nonwhite men, have a higher comorbidity burden, be insured by Medicaid, and be hospitalized in large urban, teaching hospitals. Although ARF cases increased from 1872,519 in 2016 to 3194,075 in 2019, the proportion of patients undergoing tracheal intubation declined from 23.8% to 19.8% during the same period (P < .0001). Mortality rates were higher in intubated than in nonintubated patients (P < 001). Mortality remained stable in intubated patients (30.6% [95% CI, 30.2-31.1] in 2016, versus 31.0% [95% CI, 30.5-31.4] in 2019) but decreased in nonintubated patients during the same time period (8.1% [95% CI, 7.9-8.3] versus 6.6% [95% CI, 6.5-6.8]). 10.5% of the variability in intubation rates was attributable to the admitting hospital, and sepsis was the patient factor most strongly associated with tracheal intubation. CONCLUSIONS: In the National Inpatient Sample, tracheal intubation in critically ill patients with ARF has declined over time with no change in mortality. In the same period, mortality rates in nonintubated patients have fallen. Further work is needed to better understand factors affecting the decision to intubate for respiratory failure in critically ill patients.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Karamchandani K, Iancau A, Rosero EB, et al. Trends and Variations in Tracheal Intubation for Acute Respiration Failure in Critically Ill Patients in the United States. Anesth Analg. 2026. PMID: 42485129. doi:10.1213/ANE.0000000000008154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。